Short Biography
Jan Fehr, is Professor of 'Global Health & Mobility', Head of the Department of Public & Global Health at the Epidemiology, Biostatistics and Prevention Institute (EBPI) of the University of Zurich (UZH) and one of the three members of the Executive Board of the EBPI at UZH as well as Chief Physician of the Centre for Travel Medicine (ZRM) at UZH. This is the world's only WHO Collaboration Centre for Traveller's Health and the largest travel clinic in Switzerland, with almost 30,000 consultations every year. It also includes the Canton of Zurich's reference vaccination centre, which was established during the coronavirus pandemic. He is a specialist in internal medicine and infectious diseases with many years of experience in clinical research to tackle global health changes in close collaboration with partners in the Global South. His research interests include HIV, tuberculosis, viral hepatitis, vaccinology and newly emerging infectious diseases. He is a One Health delegate of UZH for the UNA Europe Alliance, a member of the Confederate Commission for questions of vaccinations (EKIF) and a strategic member of the Swiss Expert Committee on Travel Medicine (EKRM) and member of the working group “Clinical Therapy” of the Federal Commission for Issues relating to Sexually Transmitted Infections (FCSTI) and member of the “Swiss Chagas Network”.
Curriculum Vitae
Publications list
Ongoing Projects
- A multicenter, observational cohort to study the characteristics of individuals asking for pre-exposure prophylaxis (PrEP) and the incidence of HIV and STIs: «The Swiss PrEPared Study»
- Real Risks of the Online World: Association of Online Dating Addiction with Mental and Sexual Health Outcomes in Sexual Minorities
- Seroprevalence of SARS-CoV-2 antibodies and development of immunity in the Swiss population – Population-based observational studies to inform policy making (CORONA IMMUNITAS)
- Zurich SARS-CoV-2 Cohort: Towards a long-term control of SARS-CoV-2 transmission – Identifying the epidemiological, immunological and viral genetic drivers of SARS-CoV-2 transmission and pathogenesis in a representative population-based cohort